��ɫ��

��ɫ��

Events

Resources For

Abstract Details

Title Effect of Everolimus on Tuberous Sclerosis-Related Lesions in the Brain

Topic Clinical Neurophysiology

Presentation(s) (-)

Poster/Presentation
Number 004

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
David N. Franz, MD (CCHMC/MLC 2015)	No disclosure on file
Darcy Krueger, MD (Cincinnati Children'S Hospital Medical Center)	Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NobelPharma USA. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for RegenxBio. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharmaceuticals. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwich Biosciences. The institution of Dr. Krueger has received research support from Greenwich Bioscience. The institution of Dr. Krueger has received research support from Marinus Pharmaceuticals. The institution of Dr. Krueger has received research support from National Institutes of Health. The institution of Dr. Krueger has received research support from Food and Drug Administration. The institution of Dr. Krueger has received research support from TSC Alliance.
Cameron Brennan	Cameron Brennan has nothing to disclose.
	No disclosure on file
	No disclosure on file
Katherine D. Holland, MD, PhD (Cincinnati Children's Hospital)	No disclosure on file
Karen Agricola, FNP	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file